The PharmacoMicrobiomics web portal is a part of an initiative to explore the interactions between human-associated microbes (human microbiome) and drugs by building a knowledgebase that allows interested students and investigators "to predict the behavior of untested members of drug classes or unstudied microbial species, and to design laboratory experiments for testing these predictions. (More in BMC Bioinformatics 2011, 12(Suppl 7):A10)
What to Find Here?
You will be able to find different types of information mostly related to the effect of microbes on drugs (more specifically on the effect of human microbiota on drug disposition or pharmacokinetics). In the future, there may be more information about more complex drug-microbe interactions, and about microbes as drugs, drug factories, or drug-delivery vehicles.
You now can find several entries in the database, including:
- a list of drugs with entries in the database
- the actual list of all body site-drug-microbe interactions
- a list of references to publications describing body site-drug-microbe interactions. Many of those publications have been already curated in the "relations" table, but some of them are not.
You can also find more entries still in "draft" format (mostly Google Docs) that describe a long reading/task list for our current or future curators, and also for those community volunteers who are willing to join our efforts.
Random Interaction
| Gut | |
| gliadin (17787981) | |
| Bifidobacterium bifidum (1681) | |
| 21249146 (Year: 2011) |
|
| affect N/A | |
| Fragments of the dietary wheat gluten proteins (gliadins) alone or together with the proinflammatory cytokine interferon significantly decreased the number of goblet cells in the small intestine. This effect was more pronounced in the presence of Escherichia coli and Shigella. The number of goblet cells in the small intestine increased by the simultaneous incubation of Bifidobacterium bifidum with gliadin. These results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of celiac disease pathogenesis. (See record) |
Credits
This drug-microbiome database was designed and built as the graduation project of the Open Source Technologies track at the Information Technology Institute (ITI) in June, 2011.
Django, the Python-based framework, was used to build the web portal, and JQuery libraries. JLinkPreview plugin is provided by Sarpdoruk Tahmaz. This template is distributed under a Creative Commons Attribution 2.5 License by Arcsin Web Templates. The project was hosted by WebFaction (2011-2021). It is currently hosted by Digital Ocean.